CAMBRIDGE, Mass., Nov 5, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (Nasdaq: ALKS) will host a conference call at 8:30am EST on Thursday, November 7, 2002, to discuss the Company's financial results for the second quarter. Management will review the quarter and provide an update on the company.
The conference call may be accessed by dialing 1-877-277-1426 for domestic callers and 1-334-323-4002 for international callers. The conference passcode is 42862#. Additionally, the call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com and archived on the site until Monday, November 11, 2002 at 5:00pm.
A replay of the conference call will be available from 11:30am EST on November 7, 2002 through 5:00pm EST on November 11, 2002, and may be accessed by visiting Alkermes' website or by dialing 1-888-258-7854 for domestic callers and 1-703-925-2490 for international callers. The passcode is 42862#.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to the headquarters and research and manufacturing facilities in Cambridge, Massachusetts, the company has a manufacturing facility in Chelsea, Massachusetts and a research and manufacturing facility in Ohio.
CONTACT:
Alkermes, Inc.
Rebecca Peterson, 617/583-6378